Naitik Patel, Janki Patel, Dinesh Joshi, Meena Parmar, R K Patel, Krutika Patel, Gunjan Modi
Background:
COVID-19
has forced us to alter, or perhaps it’s better said that we have had to adapt.
Within the Indian context, telemedicine has the potential to extend access to
quality healthcare for all Indians. New evidence and technological improvements
in the Telecovid application were to spot the role of its services to
screening, monitoring, and follow-up of the patients during the COVID-19
outbreak.
Subjects and Methods:
U.
N. Mehta Institute of Cardiology and Research Center has developed “TELECOVID”.
Platform with the help of HOPS by SLK Techlab, the software. Telecovid study
was started from the second wave of COVID 19 pandemic from 20th April 2021 to
27th May 2021; 24x7 hours. Patients were treated on OPD and admission according
to the institutional standard protocol which follows the guideline of the
Indian Council of Medical Research.
Results:
Total
1249 COVID patients were attended in “COVID-19 screening OPD”. There were
729(58%) males and 520(42%) females. Out of 182 admitted patients, 168(92.31%)
were discharged and 14(7.69%) were expired. More numbers of patients (83%) came
from urban and only 17% were from the rural area. Comorbidities like
hypertension were seen in a total of 97(7.77%), diabetes mellitus-II 52(4.16%)
patients were suffered. Ischemic heart disease was seen in only 10(0.8%).
Conclusion:
There
is an untapped opportunity to build our ‘UNM telemedicine’ application into a
world-class teleconsultation platform. This is potential by incorporating it
within the larger healthcare ecosystem that connects hospitals, clinics,
pharmacies, laboratories, diagnostic centers, and doctors who deal with
in-person consultations.
Comorbidities COVID-19, Digital
health, e-Follow up, India, Telecovid
VOL.14, ISSUE No.1, March 2022